← Eichor
Condition: Flu Vaccine Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Flu Vaccine

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Study of the Impact of Time of Vaccination on Response to Influenza Vaccine in Patients With Chronic Renal Failure
NA · 1 location(s) · Centre Hospitalier Universitaire de Nice · NCT06907667Covid-19 and Influenza Oral Vaccine Study
Phase 1 · 1 location(s) · Vaxine Pty Ltd · NCT06355232Clinical Trials of Quadrivalent Influenza Vaccine
Phase 1/Phase 2 · 1 location(s) · Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. · NCT06824519Phase 1/2 Study of a Plant-Based Seasonal Recombinant Trivalent VLP Influenza Vaccine
Phase 1/Phase 2 · 7 location(s) · Aramis Biotechnologies Inc. · NCT07291635Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective
Phase N/A · 1 location(s) · Institut Pasteur du Cambodge · NCT07358910Systems Investigation of Vaccine Responses in Aging and Frailty
Phase 2 · 1 location(s) · Yale University · NCT05291676Influenza Vaccine Effectiveness in Among Young Children in Taiwan
Phase N/A · 1 location(s) · National Taiwan University Hospital · NCT06446232Safety and Immunogenicity of the Monovalent Influenza Vaccine A (H5N8) (Inactivated, Fragmented and Adjuvanted) in Adult
Phase 1/Phase 2 · 5 location(s) · Butantan Institute · NCT06842173A Study to Learn About mRNA Vaccines Against Influenza in Adults
Phase 2 · 15 location(s) · Pfizer · NCT07431853Intradermal Influenza Vaccination
EARLY_Phase 1 · 1 location(s) · Yale University · NCT06067555Enhancing Maternal Vaccine Knowledge and Uptake: The InTroDuce-Programme Trial
NA · 4 location(s) · Universiti Putra Malaysia · NCT06815250Estimate the Safety and Effectiveness of Adjuvanted Influenza Vaccine Among Asian Elderly People When Compared to Non-ad
NA · 1 location(s) · National Taiwan University Hospital · NCT06676644Study of Different Formulations of Vaccines Encoding the RSV Monovalent Antigen or the Flu H5 Antigen in Participants 18
Phase 1 · 6 location(s) · Sanofi · NCT07516418Dissecting Human Immune Responses to Infection With Influenza or SARS-CoV-2
Phase N/A · 1 location(s) · Washington University School of Medicine · NCT06848309Impact Of Kidney Failure On The Regulation Of Humoral Response To Vaccination
Phase N/A · 3 location(s) · Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · NCT06635525Administration of the Nasal Influenza Vaccine to Children in Daycare or at a Healthcare Facility
NA · 1 location(s) · Turku University Hospital · NCT07310472BPL-1357 Against H1N1 Influenza Virus Challenge
Phase 2 · 2 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT07215858A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults
Phase 1 · 12 location(s) · GlaxoSmithKline · NCT07464314A Clinical Trial of Influenza Virus Split Vaccine for Individuals Aged 60 Years and Above
Phase 1 · 1 location(s) · Shanghai Institute Of Biological Products · NCT07302256Bone Marrow and Peripheral Blood Immune Responses Study
Phase 4 · 1 location(s) · Emory University · NCT05616546Understanding Immunity to the Flu Vaccine in COVID-19 Patients
Phase N/A · 1 location(s) · Stanford University · NCT04579588Effect of infLuenza vaccInation After Myocardial INfArction on Cardiac inflammaTory responsE
Phase 4 · 3 location(s) · Region Örebro County · NCT06336317Intralesional Influenza Vaccine for the Treatment of Stage I-IV Melanoma
Phase 1 · 1 location(s) · Carlo Contreras · NCT04697576High vs.Standard Dose Influenza Vaccine in Pediatric Solid Organ Transplant (SOT) Recipients
Phase 2 · 8 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT05947071High vs. Standard Dose Influenza Vaccine in Lung Allograft Recipients
Phase 2 · 1 location(s) · Vanderbilt University Medical Center · NCT05215327The INFLUENTIAL Trial- Evaluation of National Inpatient Influenza Vaccination Program
NA · 2 location(s) · University of Colorado, Denver · NCT05832307GEneRating Mucosal Immunity After INfluenzA Infection and Vaccination in Lung and Lymphoid TissuE
NA · 1 location(s) · Imperial College London · NCT06620185Quadrivalent Influenza HA Stem Vaccine VRC-FLUMOS0122-00-VP (SteMos1) With and Without ALFQ Adjuvant in Healthy Adults
Phase 1 · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT07111078Characterizing the Human Airway Immune Response to FluMist Vaccination
Phase 4 · 1 location(s) · Washington University School of Medicine · NCT07177417Evaluating the Dose, Safety, Tolerability, and Immunogenicity of Mosaic Hexavalent Influenza Vaccine VRCFLUMOS0116-00-VP
Phase 1 · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT06863142
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.